GPR143
Basic information
Region (hg38): X:9725346-9786297
Previous symbols: [ "OA1" ]
Links
Phenotypes
GenCC
Source:
- X-linked recessive ocular albinism (Supportive), mode of inheritance: XL
- X-linked recessive ocular albinism (Strong), mode of inheritance: XL
- nystagmus 6, congenital, X-linked (Strong), mode of inheritance: XL
- inherited retinal dystrophy (Definitive), mode of inheritance: XL
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Nystagmus 6, congenital, X-linked; Ocular albinism, type I | XL | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Dermatologic; Ophthalmologic | 7915878; 7647783; 8634705; 9887374; 9529334; 11214907; 11520764; 11793467; 17516023; 18523664; 19123159; 19390656; 19604113; 19610097; 20301517; 20649618; 21274678; 21348135; 21423867; 22916221 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (46 variants)
- Ocular albinism, type I (5 variants)
- Nystagmus 6, congenital, X-linked (3 variants)
- GPR143-related disorder (2 variants)
- Inborn genetic diseases (2 variants)
- Albinism (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GPR143 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 51 | 57 | ||||
missense | 125 | 149 | ||||
nonsense | 14 | 14 | ||||
start loss | 4 | |||||
frameshift | 20 | 22 | ||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 10 | 10 | 21 | |||
splice region | 2 | 4 | 8 | 1 | 15 | |
non coding | 24 | 14 | 40 | |||
Total | 52 | 22 | 126 | 80 | 28 |
Variants in GPR143
This is a list of pathogenic ClinVar variants found in the GPR143 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-9725612-G-A | Benign (May 12, 2021) | |||
X-9725758-A-C | Uncertain significance (Jun 05, 2022) | |||
X-9725759-T-C | Inborn genetic diseases | Uncertain significance (May 30, 2024) | ||
X-9725768-A-G | Benign (Jan 21, 2024) | |||
X-9725769-G-A | Uncertain significance (Apr 04, 2022) | |||
X-9725772-C-A | Uncertain significance (Jul 28, 2023) | |||
X-9725779-A-G | Likely benign (Nov 27, 2023) | |||
X-9725790-T-C | Uncertain significance (Mar 28, 2022) | |||
X-9725804-C-T | Inborn genetic diseases | Uncertain significance (Jun 05, 2022) | ||
X-9725805-T-C | GPR143-related disorder | Uncertain significance (Jul 07, 2023) | ||
X-9725806-T-G | Benign (Jul 19, 2023) | |||
X-9725810-G-A | Uncertain significance (Jan 28, 2021) | |||
X-9725810-G-C | Uncertain significance (Oct 20, 2023) | |||
X-9725816-A-T | Uncertain significance (Nov 07, 2023) | |||
X-9725822-A-G | Uncertain significance (Mar 16, 2023) | |||
X-9725828-C-T | Benign (Jan 02, 2024) | |||
X-9725831-G-A | Uncertain significance (Jul 07, 2023) | |||
X-9725844-G-C | Likely benign (Jul 15, 2022) | |||
X-9739333-G-A | Benign (May 12, 2021) | |||
X-9739465-T-C | Likely benign (Oct 21, 2021) | |||
X-9739469-G-A | not specified | Benign (Jan 15, 2024) | ||
X-9739470-C-A | Benign (Jan 12, 2024) | |||
X-9739472-G-A | Likely benign (Dec 18, 2022) | |||
X-9739474-CAG-C | Likely benign (Sep 03, 2022) | |||
X-9739481-T-C | not specified | Benign (Jan 29, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GPR143 | protein_coding | protein_coding | ENST00000467482 | 9 | 60952 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.925 | 0.0747 | 125686 | 6 | 10 | 125702 | 0.0000636 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.879 | 111 | 140 | 0.791 | 0.0000108 | 2562 |
Missense in Polyphen | 26 | 51.408 | 0.50576 | 979 | ||
Synonymous | -0.161 | 64 | 62.4 | 1.03 | 0.00000541 | 853 |
Loss of Function | 3.04 | 1 | 12.7 | 0.0788 | 8.78e-7 | 211 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000952 | 0.000775 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000724 | 0.0000544 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000126 | 0.00000879 |
Middle Eastern | 0.0000724 | 0.0000544 |
South Asian | 0.0000528 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Receptor for tyrosine, L-DOPA and dopamine. After binding to L-DOPA, stimulates Ca(2+) influx into the cytoplasm, increases secretion of the neurotrophic factor SERPINF1 and relocalizes beta arrestin at the plasma membrane; this ligand- dependent signaling occurs through a G(q)-mediated pathway in melanocytic cells. Its activity is mediated by G proteins which activate the phosphoinositide signaling pathway. Plays also a role as an intracellular G protein-coupled receptor involved in melanosome biogenesis, organization and transport. {ECO:0000269|PubMed:10471510, ECO:0000269|PubMed:16524428, ECO:0000269|PubMed:18697795, ECO:0000269|PubMed:18828673, ECO:0000269|PubMed:19717472}.;
- Disease
- DISEASE: Albinism ocular 1 (OA1) [MIM:300500]: Form of albinism affecting only the eye. Pigment of the hair and skin is normal or only slightly diluted. Eyes may be severely affected with photophobia and reduced visual acuity. Nystagmus or strabismus are often associated. The irides and fundus are depigmented. {ECO:0000269|PubMed:11115845, ECO:0000269|PubMed:11214907, ECO:0000269|PubMed:16524428, ECO:0000269|PubMed:16621890, ECO:0000269|PubMed:16646960, ECO:0000269|PubMed:17822861, ECO:0000269|PubMed:17960122, ECO:0000269|PubMed:18697795, ECO:0000269|PubMed:18978956, ECO:0000269|PubMed:8634705, ECO:0000269|PubMed:9529334, ECO:0000269|PubMed:9887374}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Nystagmus congenital X-linked 6 (NYS6) [MIM:300814]: A condition defined as conjugated, spontaneous and involuntary ocular oscillations that appear at birth or during the first three months of life. Other associated features may include mildly decreased visual acuity, strabismus, astigmatism, and occasionally head nodding. {ECO:0000269|PubMed:17516023}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- GPCRs, Other;Signaling by GPCR;Signal Transduction;Amine ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;G alpha (q) signalling events;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.227
Intolerance Scores
- loftool
- 0.0848
- rvis_EVS
- 0.02
- rvis_percentile_EVS
- 55.45
Haploinsufficiency Scores
- pHI
- 0.104
- hipred
- Y
- hipred_score
- 0.644
- ghis
- 0.520
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.231
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gpr143
- Phenotype
- nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); vision/eye phenotype; pigmentation phenotype;
Zebrafish Information Network
- Gene name
- gpr143
- Affected structure
- retinal pigmented epithelium
- Phenotype tag
- abnormal
- Phenotype quality
- decreased pigmentation
Gene ontology
- Biological process
- eye pigment biosynthetic process;signal transduction;G protein-coupled receptor signaling pathway;neuropeptide signaling pathway;visual perception;melanosome localization;melanosome transport;melanosome organization;calcium-mediated signaling using intracellular calcium source;phosphatidylinositol-mediated signaling;regulation of calcium-mediated signaling;regulation of melanosome transport;regulation of melanosome organization
- Cellular component
- cytoplasm;lysosomal membrane;Golgi apparatus;plasma membrane;membrane;integral component of membrane;apical plasma membrane;melanosome membrane;melanosome
- Molecular function
- G protein-coupled receptor activity;protein binding;dopamine binding;L-DOPA receptor activity;L-DOPA binding;tyrosine binding